肌萎缩侧索硬化诊断与预后研究新进展
综述阐述肌萎缩侧索硬化因临床表现异质性和与其他神经疾病重叠而诊断困难,早期诊断可及时干预延缓进展;新诊断标准如Gold Coast标准或可加速诊断,ENCaLS生存模型等预后工具可帮助沟通病程与终末期规划,新分期评分系统和液体生物标志物、影像、神经肌肉电生理等工具有望提高诊断和预后准确性。
要点
- 肌萎缩侧索硬化诊断因临床异质性和疾病重叠而具有挑战性,早期诊断可及时干预以延缓疾病进展。
- 对基因型和表型认识的不断深入以及Gold Coast等新诊断标准可能加速诊断。
- ENCaLS生存模型等改进的预后评估可帮助患者及家属了解病程并改善终末期规划。
核心结论
- 新诊断标准、预后模型、分期评分系统及液体生物标志物、影像和神经肌肉电生理等新工具有望提高肌萎缩侧索硬化的诊断和预后准确性。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 肌萎缩侧索硬化诊断因临床表现异质性和与其他神经疾病重叠而具有挑战性,早期诊断可及时干预以延缓疾病进展。
- 对疾病基因型和表型认识的不断深入以及Gold Coast等新诊断标准可能加速诊断。
- ENCaLS生存模型等改进的预后评估可帮助患者及家属了解病程并改善终末期规划。
- 新分期和评分系统可帮助监测疾病进展,并可能作为临床试验结局指标。
- 液体生物标志物、影像模式和神经肌肉电生理测量等新工具可能提高诊断和预后准确性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The diagnosis of amyotrophic lateral sclerosis can be challenging due to its heterogeneity in clinical presentation and overlap with other neurological disorders. Diagnosis early in the disease course can improve outcomes as timely interventions can slow disease progression. An evolving awareness of disease genotypes and phenotypes and new diagnostic criteria, such as the recent Gold Coast criteria, could expedite diagnosis. Improved prognosis, such as that achieved with the survival model from the European Network for the Cure of ALS, could inform the patient and their family about disease course and improve end-of-life planning. Novel staging and scoring systems can help monitor disease progression and might potentially serve as clinical trial outcomes. Lastly, new tools, such as fluid biomarkers, imaging modalities, and neuromuscular electrophysiological measurements, might increase diagnostic and prognostic accuracy.
引用
- Goutman SA, Hardiman O, Al-Chalabi A, et al. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. 2022. PMID: 35334233. doi:10.1016/S1474-4422(21)00465-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。